Progeny 3 Portfolio holdings
Progeny 3 is a family office that handles investment management, tax reporting and estate planning for the Smith Hemingway family, owners of the port operator Carrix. Jon Hemingway, who chaired Carrix, led its creation in 2007. That was the year the family sold part of its interest in Carrix to a financial partner.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cameco
CCJ
|
+$5.72M |
| 2 |
Twist Bioscience
TWST
|
+$4.98M |
| 3 |
iShares MSCI Saudi Arabia ETF
KSA
|
+$967K |
| 4 |
Global X MSCI Greece ETF
GREK
|
+$751K |
| 5 |
Global X MSCI Argentina ETF
ARGT
|
+$361K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Trust Short MSCI Emerging Markets
EUM
|
+$985K |
| 2 |
ProShares Short QQQ
PSQ
|
+$915K |
| 3 |
Alerian MLP ETF
AMLP
|
+$254K |
| 4 |
Uranium Energy
UEC
|
+$217K |
| 5 |
Transportadora de Gas del Sur
TGS
|
+$162K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 86.84% |
| 2 | Energy | 7.14% |
| 3 | Healthcare | 5.74% |
| 4 | Materials | 0.29% |
| 5 | Financials | 0% |
Similar funds
Progeny 3's Q2 2019 Portfolio in Review
As of Q2 2019, Progeny 3 held 24 positions worth $95.1M, up 15% from $82.9M the previous quarter. Its ten largest holdings account for 96% of the portfolio.
Progeny 3 deployed $10M of net new capital in Q2 2019, opening 2 new positions and adding to 8 existing holdings. Its largest new stake was Twist Bioscience: 188,282 shares worth $5.46M.
By sector, the portfolio is most concentrated in Miscellaneous at 87% of assets, down from 98% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Alerian MLP ETF, an estimated $254K trimmed.
- Progeny 3's largest Q2 2019 buy was Twist Bioscience: 188,282 shares worth $5.46M.
- Progeny 3 added most to Cameco in Q2 2019, an estimated $5.72M increase.
- Progeny 3's biggest Q2 2019 reduction was Alerian MLP ETF, cutting an estimated $254K.
- Progeny 3 fully exited ProShares Trust Short MSCI Emerging Markets in Q2 2019, selling an estimated $985K.
- Progeny 3's ten largest holdings make up 96% of its $95.1M portfolio in Q2 2019.
- Progeny 3 opened 2 new positions and closed 8 in Q2 2019.
- Progeny 3's portfolio value rose 15% quarter-over-quarter to $95.1M.
Based on Progeny 3's 13F filing for Q2 2019, filed 14 Aug 2019.